Literature DB >> 18727642

Chronic daily headache in Brazil: a nationwide population-based study.

L P Queiroz1, M F P Peres, F Kowacs, E J Piovesan, M C Ciciarelli, J A Souza, E Zukerman.   

Abstract

The objectives of this study were to estimate the 1-year prevalence of chronic daily headache (CDH) and the degree of the association of CDH with some sociodemographic characteristics of the adult population of Brazil. This was a cross-sectional, population-based study. We conducted telephone interviews with 3848 people, aged 18-79 years, randomly selected from the 27 States of Brazil. The degree of the association was calculated through prevalence ratios, adjusted with Poisson regression by gender, age and some sociodemographic factors. The estimated 1-year gender- and age-adjusted prevalence of CDH was 6.9%. CDH was 2.4 times more prevalent in women, 1.72 times more in unemployed, 1.63 times more in subjects with high household income and two times greater in those who did not exercise. The overall prevalence of CDH in Brazil is high. CDH is significantly more prevalent in women, the unemployed, subjects with higher income, and in those who do not exercise.

Entities:  

Mesh:

Year:  2008        PMID: 18727642     DOI: 10.1111/j.1468-2982.2008.01670.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  11 in total

1.  Reduced flexion rotation test in women with chronic and episodic migraine.

Authors:  Ana Izabela S Oliveira-Souza; Lidiane L Florencio; Gabriela F Carvalho; César Fernández-De-Las-Peñas; Fabiola Dach; Debora Bevilaqua-Grossi
Journal:  Braz J Phys Ther       Date:  2019-01-16       Impact factor: 3.377

Review 2.  Medication Overuse Headache: The Reason of Headache That Common and Preventable.

Authors:  Elif Kocasoy Orhan; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

Review 3.  The prevalence of headache may be related with the latitude: a possible role of Vitamin D insufficiency?

Authors:  Sanjay Prakash; Nivedita C Mehta; Ajay S Dabhi; Om Lakhani; Madhuri Khilari; Nilima D Shah
Journal:  J Headache Pain       Date:  2010-05-13       Impact factor: 7.277

Review 4.  Risk factors of chronic daily headache or chronic migraine.

Authors:  Soo-Jin Cho; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2015-01

5.  Epidemiology and clinical characteristics of chronic daily headache in a clinic-based cohort of Iranian population.

Authors:  Seyed Mohammad Seyed Saadat; Mozaffar Hosseininezhad; Babak Bakhshayesh; Mahsa Hoseini; Mohamadreza Naghipour
Journal:  Neurol Sci       Date:  2013-09-26       Impact factor: 3.307

Review 6.  Psychological trauma in chronic pain: implications of PTSD for fibromyalgia and headache disorders.

Authors:  Julio F P Peres; Andre Leite Gonçalves; Mario F P Peres
Journal:  Curr Pain Headache Rep       Date:  2009-10

7.  Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management.

Authors:  Jeong-Wook Park; Heui-Soo Moon; Jae-Moon Kim; Kwang-Soo Lee; Min Kyung Chu
Journal:  J Clin Neurol       Date:  2014-07-03       Impact factor: 3.077

Review 8.  From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries.

Authors:  Marta Allena; Zaza Katsarava; Giuseppe Nappi
Journal:  J Headache Pain       Date:  2009-02-24       Impact factor: 7.277

9.  Prevalence and predictors of headache in patients referred to polysomnography.

Authors:  Kornelia Katalin Beiske; Michael Bjørn Russell; Knut Stavem
Journal:  J Headache Pain       Date:  2013-11-18       Impact factor: 7.277

10.  Chronic Daily Headache and Medication Overuse Headache in First-Visit Headache Patients in Korea: A Multicenter Clinic-Based Study.

Authors:  Myoung Jin Cha; Heui Soo Moon; Jong Hee Sohn; Byung Su Kim; Tae Jin Song; Jae Moon Kim; Jeong Wook Park; Kwang Yeol Park; Soo Kyoung Kim; Byung Kun Kim; Soo Jin Cho
Journal:  J Clin Neurol       Date:  2016-07       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.